Prochlorperazine
Compro
Phenothiazine
NADAC/unit
$0.1215
No Shortage
Tier 1: 105.5%
PA Req: 4.3%
21 Manufacturers
31 ANDAs
Prochlorperazine treats psychotic disorders and severe nausea by blocking dopamine receptors.
vs. brand Compro: Generic saves up to 99% per unit
Market Intelligence
2023-01-11 Class III Recall: Jubilant Cadista Pharmaceuticals, Inc.
Generic Manufacturers
AJANTA PHARMA LTDAMNEAL EU LTDAUROBINDO PHARMA LTDAVET LIFESCIENCES LTDBIONPHARMA INCCAPLIN STERILES LTDCOSETTE PHARMACEUTICALS INCDR REDDYS LABORATORIES SAEUGIA PHARMA SPECIALITIES LTDGLAND PHARMA LTDGLENMARK PHARMACEUTICALS LTDHIKMA PHARMACEUTICALS USA INCJUBILANT CADISTA PHARMACEUTICALS INCLEADING PHARMA LLCMYLAN LABORATORIES LTDNOVITIUM PHARMA LLCPADAGIS US LLCSAGENT PHARMACEUTICALSSOMERSET THERAPEUTICS LLCVIWIT PHARMACEUTICAL CO LTDZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.